Nephrogenic fibrosing dermopathy in children springerlink. A case of nephrogenic fibrosing dermopathynephrogenic. Marckmann p, skov l, rossen k, dupont a, damholt mb, heaf jg. Nephrogenic fibrosing dermopathy associated with exposure to. Background nephrogenic fibrosing dermopathynephrogenic systemic fibrosis nfdnsf is a fibrosing cutaneous disorder recently recognized to have systemic manifestations. Nephrogenic systemic fibrosis is a progressive, potentially fatal multiorgan system fibrosing disease related to exposure of patients with renal failure to. Nephrogenic systemic fibrosis is a rare disease that occurs mainly in people with advanced kidney failure with or without dialysis. Nephrogenic systemic fibrosis radiology reference article. Nephrogenic fibrosing dermopathy, also known as nephrogenic systemic fibrosis, is a recently described acquired, idiopathic disorder that manifests in patients with renal disease. Nephrogenic systemic fibrosis is a rare condition, and cases should be reported to the international center for nephrogenic fibrosing dermopathy research at yale. Nephrogenic systemic fibrosis clinical presentation. Nephrogenic systemic fibrosis fulltext american journal of. Nephrogenic fibrosing dermopathy nfd is an acquired, idiopathic disorder that is observed in patients with renal disease. Nephrogenic fibrosing dermopathynephrogenic systemic.
Apr 24, 20 nephrogenic systemic fibrosis is a condition that affects different parts of the body, particularly the skin. Nephrogenic fibrosing dermopathy nfd is an acquired, idiopathic, chronic, progressive eruption of the skin sometimes accompanied by systemic fibrosis that occurs in the context of renal failure. Furthermore, they extracted the risk factors, clinical data, outcomes and possible treatment in patients with biopsyverified nsf. Nephrogenic systemic fibrosis nsf, also known as nephrogenic fibrosing dermopathy nfd, is a disease of fibrosis of the skin and internal organs reminiscent but distinct from scleroderma or scleromyxedema. Abraham, mdc nashville, tennessee, and syracuse, new york there is growing recognition of the association between the use of gadoliniumcontaining radiocontrast. A 75yearold woman with endstage renal disease on hemodialysis presented with a 2month history of progressive skin thickening of the lower extremities. Eventually, flexure contractures develop, with restriction to movement, pain.
Nephrogenic fibrosing dermopathy nfd is a progressive disorder which has been shown to occur in those with chronic kidney problems or impaired renal function. Nephrogenic fibrosing dermopathy predominantly affects the skin, but abnormal fibrosis of the internal organs may also occur, which is then often called nephrogenic systemic fibrosis. Nephrogenic systemic fibrosisnephrogenic fibrosing dermopathy in. Nephrogenic fibrosing dermopathy nfd is a rare condition in which there is a sudden onset of nodular or plaquelike skin lesions. Since then, more than 360 cases have been tracked by the yale international nsf registry 2 and over 500 cases have been reported to the.
Nephrogenic fibrosing dermopathynephrogenic systemic fibrosissetting the. Dermoscopy is a diagnostic tool where a dermatologist examines the skin using a special magnified lens. Nephrogenic fibrosing dermopathy is a rare condition that results in tightened, swollen skin. Nephrogenic systemic fibrosis nsf nephrogenic fibrosing dermopathy nfd is a. It was first described in patients with kidney disease in 1997. Most patients with nfd have undergone dialysis for renal failure 1,2. Nephrogenic fibrosing dermopathy with systemic involvement. Nephrogenic fibrosing dermopathynephrogenic systemic fibrosissetting the record straight. It is very common for renal patients to have undergone a vascular procedure, such as av fistula formation before starting haemodialysis. Nephrogenic fibrosing dermopathy in pediatric patients. The skin findings are similar to those seen in patients with scleroderma. Most cases have been reported in the us and europe, but recently cases have also been.
Nephrogenic systemic fibrosis nsf is a rare, potentially fatal condition caused by iatrogenic gadolinium administration in patients with acute kidney injury or stage 4 or 5 chronic kidney disease ckd, defined as an estimated glomerular filtration rate egfr of less than 30 mlmin1. Observational study on the incidence of nephrogenic systemic fibrosis in renal impaired patients following gadoterate meglumine administration. Clinically, these patients present with sclerodermalike plaques often involving the extremities. The condition can resemble scleroderma in appearance. Pdf gadoliniumassociated nephrogenic systemic fibrosis. Gadoliniuma specific trigger for the development of. Nephrogenic fibrosing dermopathy lawsuits lawyers attorneys. Nephrogenic systemic fibrosis is a recently recognized disease entity that is. Although initially recognized as a cutaneous disorder and named nephrogenic fibrosing dermopathy, extensive systemic involvement has been identified in patients with nsf, including fibrosis of lymph nodes, thyroid, esophagus, heart, lungs, liver, diaphragm, skeletal muscle, genitourinary tract, and dura mater 7, 8.
Grobner t 2006 erratum gadolinium a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis. Minimizing risk of nephrogenic systemic fibrosis in. The exact pathogenesis of nephrogenic systemic fibrosis is unclear, but the disease has been linked with the use of gadoliniumbased contrast agents, predominantly in patients with acute renal failure or endstage renal disease. The link between nephrogenic systemic fibrosis nsf and gadoliniumbased contrast agents gbcas was made in 20061,2. Pdf nephrogenic systemic fibrosis nsf is a multisystem disease seen. Nephrogenic fibrosing dermopathy associated with exposure.
Laboratory values at admission are shown in table 1. Dialysisassociated systemic fibrosis nephrogenic fibrosing dermopathy. The degree and cause of the underlying renal impairment seem not to be related to the severity of the nephrogenic fibrosing dermopathy. They searched pubmed from january 2000 to february 2019 according to the key words nephrogenic systemic fibrosis, nsf and nephrogenic fibrosing dermopathy. Nephrogenic systemic fibrosis nsf, previously called nephrogenic fibrosing dermopathy, is an acquired, progressive, systemic fibrosing disorder of unknown etiology that develops in the setting of renal disease. Louis, missouri, 20022006 nephrogenic fibrosing dermopathy nfd causes thickening and hardening of the skin, often in the extremities, and occurs in patients with underlying renal disease. Nephrogenic systemic fibrosis nsf is a rare disease that occurs in patients with renal failure. Nephrogenic systemic fibrosis nsf is a disorder seen only in patients with advanced kidney disease and is characterized by two primary features. Later this entity was renamed nephrogenic systemic fibrosis nsf when involvement of internal organs was discovered. Risk of nephrogenic systemic fibrosis in patients with stage. Nephrogenic systemic fibrosis nsf was originally called nephrogenic fibrosing dermopathy because of its predilection for extensive cutaneous involvement, but the newer term is more apt, because the condition involves extracutaneous tissues.
The disease is characterized clinically by an acute onset of hardening and thickening of the skin of the extremities and trunk, often resulting in flexion contractures, and histologically by an increase in spindle. Nephrogenic systemic fibrosis may resemble skin diseases, such as scleroderma and scleromyxedema, with thickening and darkening developing on large areas of the skin. Nephrogenic systemic fibrosis an overview sciencedirect. It is a condition normally found in people with kidney disease. Nephrogenic systemic fibrosis nsf, initially named nephrogenic fibrosing dermopathy, was first reported in 2001bycowperetal. Nephrogenic systemic fibrosisnephrogenic fibrosing dermopathy. Nephrogenic systemic fibrosis nsf is a rare disease involving severe thickening and hardening of the skin fibrosis overlying the extremities and trunk. Gadolinium a specific trigger for the development of. Nephrogenic systemic fibrosis nsf is the thickening and hardening of your skin, mostly on your arms and legs. This results in thick, coarse and hard skin, which make it difficult to move the arms, hands, legs andor feet. Gadolinium deposition and nephrogenic systemic fibrosis. May 22, 2018 kucher c, steere j, elenitsas r, siegel dl, xu x. Systemic findings seen in scleromyxedema, which the condition resembles in some respects, were absent.
Nephrogenic systemic fibrosis nsf, previously known as nephrogenic fibrosing dermopathy, is an emerging systemic fibrosing disorder that develops in the setting of renal insufficiency. Pediatric nephrogenic systemic fibrosis is rarely reported. The age of patients with nfd ranges from 8 to 87 years at the time of onset, with a mean age of 46. The first trial over nephrogenic systemic fibrosis nsf from omniscan, a gadoliniumbased mri contrast agent manufactured by ge healthcare, was settled in a. Theearliestknowncaseofnsf developed in january 1997. Nephrogenic systemic fibrosis genetic and rare diseases. Pdf gadolinium deposition in nephrogenic fibrosing. Nephrogenic fibrosing dermopathynephrogenic systemic fibrosis with diaphragmatic involvement in a patient with respiratory failure. Gadolinium deposition in nephrogenic fibrosing dermopathy. Oct 01, 2009 nephrogenic systemic fibrosis is a progressive, potentially fatal multiorgan system fibrosing disease related to exposure of patients with renal failure to the gadoliniumbased contrast agents. Aug 21, 2012 nephrogenic fibrosing dermopathy nfd is an acquired, idiopathic, chronic, progressive eruption of the skin sometimes accompanied by systemic fibrosis that occurs in the context of renal failure. Nephrogenic systemic fibrosis differential diagnoses.
Nephrogenic fibrosing dermopathy associated with exposure to gadoliniumcontaining contrast agents st. Nephrogenic systemic fibrosisnephrogenic fibrosing. Symptoms of the condition may include progressive swelling and tightening of the skin, sometimes resulting in contractures, and pruritis itching. Feb 03, 2020 what is nephrogenic systemic fibrosis. It is caused by gadolinium exposure used in imaging in patients who have renal insufficiency. Symptoms nephrogenic systemic fibrosis diagnosis nsf. Previously called nephrogenic fibrosing dermopathy case reports 61 year old woman with nephrogenic systemic fibrosis mimicking inflammatory breast carcinoma arch pathol lab med 2007. Diagnostic tests that are performed for nephrogenic fibrosing dermopathy may include. Byung chul kang1 1chung ang university hospital, seoul, korea purpose. However, in 1997, a new disease emerged, originally called nephrogenic fibrosing dermopathy. It is associated with fibrosis, or scarring, which results in thick, coarse and hard skin around the joints, which can severely restrict movements. Skin thickening, tightness and contractures are hallmarks of the clinical findings in nephrogenic fibrosing dermopathy. Nephrogenic systemic fibrosis what you need to know.
The exact pathogenesis of nephrogenic systemic fibrosis is unclear, but the disease has been linked with the use of gadoliniumbased contrast agents, predominantly in patients with acute renal failure or. It has characteristic diagnostic findings by skin biopsy and due to its systemic involvement in some reported cases, the term nephrogenic systemic fibrosis has been recently suggested as more appropriate for the nomenclature of this entity. The disease is characterized clinically by an acute onset of hardening and thickening of the skin of the extremities and trunk, often resulting in flexion contractures, and. By routine microscopy, the findings range from a very subtle proliferation of dermal fibroblasts in. Cutaneous changes of nephrogenic systemic fibrosis. Nephrogenic fibrosing dermopathy bahar f firoz md mph, christopher m hunzeker md, anthony c soldano md, andrew g franks jr md dermatology online journal 14 5. Nephrogenic systemic fibrosis nsf, also known as nephrogenic fibrosing dermopathy, is a complication of gadoliniumbased contrast agents used in mri. Your muscles, joints, organs, and the tissue that covers your brain may also be affected. The cause of nephrogenic systemic fibrosis is attributed to the connexation of renal insufficiency and. Nephrogenic systemic fibrosis nsf was first recognized in 1997 and. Any information contained in this pdf file is automatically generated from digital material submitted to epos by third parties in the form of scientific presentations. The purpose of this article is to discuss nephrogenic systemic fibrosis nsf in detail regarding its history, possible pathophysiology, clinical and pathologic presentations, diagnosis, and implications for the radiology community.
Nephrogenic fibrosing dermopathy is an acquired sclerodermalike. Nephrogenic fibrosing dermopathy has also been seen in patients with clotting problems or who have had recent surgery particularly vascular surgery. Many endogenous as well as exogenous factors have been implicated in the. Gadoliniuma specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis. West of scotland experience of nephrogenic systemic fibrosis in. Epidemiological studies suggest that the incidence of nsf is unrelated to gender or ethnicity and it is not thought to have a genetic basis. It was first described by cowper in 2001 and the relationship to gbca exposure has been strongly suspected since 2006 37. Gadoliniumassociated nephrogenic systemic fibrosis. Nsf is caused by exposure to gadolinium in gadoliniumbased mri contrast agents gbcas in patients with impaired kidney function. Nephrogenic systemic fibrosis is a rare syndrome that involves fibrosis of skin, joints, eyes, and internal organs. It is characterized by firm, erythematous, and indurated plaques of the skin associated with subcutaneous edema 1.
Gadolinium a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis. Nephrogenic fibrosing dermopathy nephrogenic systemic fibrosis with diaphragmatic involvement in a patient with respiratory failure. Nephrogenic fibrosing dermopathy is a recently described fibrosing disorder that emerges in different settings of renal insufficiency. Nephrogenic systemic fibrosis is a condition that affects different parts of the body, particularly the skin. It is chiefly seen in patients of chronic kidney disease, those on hemodialysis and those who have had a history of exposure to gadoliniumbased contrast media. Recently described systemic fibrosing disorder primarily affecting patients with chronic renal insufficiency exposed to gadolinium based contrast agents clin j am soc nephrol 2010. Nephrogenic systemic fibrosis is a recently recognized disease entity that is potentially debilitating. Nephrogenic systemic fibrosis, also known as nephrogenic fibrosing dermopathy, is associated with the formation of excessive scar tissue in the skin and connective tissue of other internal organs. Eventually, flexure contractures develop, with restriction to movement, pain and pruritus. Dec 06, 2019 nephrogenic fibrosing dermopathynephrogenic systemic fibrosis with diaphragmatic involvement in a patient with respiratory failure. A thorough physical examination and evaluation of a complete medical history. Nephrogenic systemic fibrosis is a disorder primarily affecting middleaged adults, although there is no racial or sex predilection for this disorder. Nephrogenic fibrosing dermopathy nfd is an entity of unknown etiology that has only been reported in patients with impaired kidney function.
706 1240 1008 327 610 240 718 497 1214 786 869 1270 1215 1437 963 355 1350 995 166 957 807 73 1059 1074 1217 523 1445 1047